Vecchio G - Search Results

1

Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors.

Carlomagno F, Guida T, Anaganti S, Vecchio G, Fusco A, Ryan AJ, Billaud M, Santoro M. Carlomagno F, et al. Among authors: vecchio g. Oncogene. 2004 Aug 12;23(36):6056-63. doi: 10.1038/sj.onc.1207810. Oncogene. 2004. PMID: 15184865

2

The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes.

Carlomagno F, Vitagliano D, Guida T, Napolitano M, Vecchio G, Fusco A, Gazit A, Levitzki A, Santoro M. Carlomagno F, et al. Among authors: vecchio g. Cancer Res. 2002 Feb 15;62(4):1077-82. Cancer Res. 2002. PMID: 11861385

3

Molecular mechanisms of RET activation in human cancer.

Santoro M, Melillo RM, Carlomagno F, Fusco A, Vecchio G. Santoro M, et al. Among authors: vecchio g. Ann N Y Acad Sci. 2002 Jun;963:116-21. doi: 10.1111/j.1749-6632.2002.tb04102.x. Ann N Y Acad Sci. 2002. PMID: 12095936

4

ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.

Carlomagno F, Vitagliano D, Guida T, Ciardiello F, Tortora G, Vecchio G, Ryan AJ, Fontanini G, Fusco A, Santoro M. Carlomagno F, et al. Among authors: vecchio g. Cancer Res. 2002 Dec 15;62(24):7284-90. Cancer Res. 2002. PMID: 12499271

5

Minireview: RET: normal and abnormal functions.

Santoro M, Melillo RM, Carlomagno F, Vecchio G, Fusco A. Santoro M, et al. Among authors: vecchio g. Endocrinology. 2004 Dec;145(12):5448-51. doi: 10.1210/en.2004-0922. Epub 2004 Aug 26. Endocrinology. 2004. PMID: 15331579 Review.

6

RET is a heat shock protein 90 (HSP90) client protein and is knocked down upon HSP90 pharmacological block.

Alfano L, Guida T, Provitera L, Vecchio G, Billaud M, Santoro M, Carlomagno F. Alfano L, et al. Among authors: vecchio g. J Clin Endocrinol Metab. 2010 Jul;95(7):3552-7. doi: 10.1210/jc.2009-2315. Epub 2010 May 5. J Clin Endocrinol Metab. 2010. PMID: 20444924

7

Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells.

Califano D, Monaco C, de Vita G, D'Alessio A, Dathan NA, Possenti R, Vecchio G, Fusco A, Santoro M, de Franciscis V. Califano D, et al. Among authors: vecchio g. Oncogene. 1995 Jul 6;11(1):107-12. Oncogene. 1995. PMID: 7624117

8

Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo.

Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM, Vecchio G. Grieco M, et al. Among authors: vecchio g. Oncogene. 1994 Sep;9(9):2531-5. Oncogene. 1994. PMID: 8058316

9

Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.

Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A. Santoro M, et al. Among authors: vecchio g. Oncogene. 1994 Feb;9(2):509-16. Oncogene. 1994. PMID: 8290261

10

Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.

Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A. Santoro M, et al. Among authors: vecchio g. Oncogene. 1996 Apr 18;12(8):1821-6. Oncogene. 1996. PMID: 8622903

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

570 results

Search Page

Filters